Sign inJoin waitlistJoin the waitlist

IH

Iftikhar Hussain

Physician · Mind Rejuvenation, Llc.

Credentials: · · · · ·

History

Mind Rejuvenation, Llc.
2025–Present

University of Minnesota
1992–1993
Internal Medicine
1989–1992
Doctor of Medicine
1985–1989

Research

Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program
Journal of Allergy and Clinical Immunology · 2007 · 754 citations
Dupilumab shows long-term safety and efficacy in patients with moderate to severe atopic dermatitis enrolled in a phase 3 open-label extension study
Journal of the American Academy of Dermatology · 2020 · 206 citations
Epithelial cell proliferation contributes to airway remodeling in severe asthma
American Journal of Respiratory and Critical Care Medicine · 2007 · 188 citations

Joel Kline
9 papers
Kenneth Paris
4 papers
LY
Leman Yel
4 papers
MS
Mark Stein
4 papers
VJ
Vipul Jain
4 papers · 3 as a fellow
AD
Amy Darter
3 papers
SG
Sudhir Gupta
3 papers
WL
William Lumry
3 papers
AB
Andrew Blauvelt
2 papers
DS
Daniel Suez
2 papers
DG
David Gelmont
2 papers
DL
Donald Levy
2 papers

Clinical trials

Efficacy and Safety of 186 mcg of OPN-375 Nasal Spray Twice a Day (BID) in Adolescents With Chronic Rhinosinusitis Without Nasal Polyps
Site PI · Recruiting · Phase 3
Optinose US Inc.
2025–2028
A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines
Site PI · Recruiting · Phase 3
Novartis Pharmaceuticals
2025–2027
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
Site PI · Recruiting · Phase 3
Eli Lilly and Company
2023–2033